| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
Dezember 2019 - 44 Präparate |
|
L | | FI | | | Bortezomib liquid Spirig HC 3.5 mg/1.4 ml | | 372.78 | 444.80 | 10% | | Injektionslösung: Bortezomibum 3.5mg / 1.4ml | Spirig HealthCare AG | A / SL / SG | FB | | G | |
L | | FI | | | Bortezomib liquid Spirig HC 7 mg/2.8 ml | | 641.18 | 753.20 | 10% | | Injektionslösung: Bortezomibum 7mg / 2.8ml | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | FI | | | Voriconazole Accord 200mg | | 132.94 | 169.20 | 10% | | Lyophilisat: Voriconazolum 200 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
L | | FI | PI | | Rosuvastatin NOBEL 5 mg | 30 | 7.12 | 16.40 | 10% | | Filmtabletten: Rosuvastatinum 5 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G | |
L | | FI | PI | | Rosuvastatin NOBEL 5 mg | 105 | 24.93 | 45.05 | 10% | | Filmtabletten: Rosuvastatinum 5 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G | |
L | | FI | | | Rosuvastatin NOBEL 10 mg | 30 | 8.12 | 17.55 | 10% | | Filmtabletten: Rosuvastatinum 10 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G | |
L | | FI | | | Rosuvastatin NOBEL 10 mg | 105 | 28.43 | 49.10 | 10% | | Filmtabletten: Rosuvastatinum 10 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G | |
L | | FI | | | Rosuvastatin NOBEL 20 mg | 30 | 11.78 | 25.85 | 10% | | Filmtabletten: Rosuvastatinum 20 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G | |
L | | FI | | | Rosuvastatin NOBEL 20 mg | 105 | 41.24 | 63.80 | 10% | | Filmtabletten: Rosuvastatinum 20 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G | |
| | FI | PI | | Temozolomid Accord 5 mg | 5 | 10.45 | 20.20 | 10% | | Kapseln: Temozolomidum 5 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | FI | PI | | Temozolomid Accord 5 mg | 20 | 38.36 | 60.50 | 10% | | Kapseln: Temozolomidum 5 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | FI | | | Temozolomid Accord 20 mg | 5 | 41.80 | 64.45 | 10% | | Kapseln: Temozolomidum 20 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | FI | | | Temozolomid Accord 20 mg | 20 | 148.23 | 186.75 | 10% | | Kapseln: Temozolomidum 20 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | FI | | | Temozolomid Accord 100 mg | 5 | 177.92 | 220.85 | 10% | | Kapseln: Temozolomidum 100 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | FI | | | Temozolomid Accord 100 mg | 20 | 626.90 | 736.80 | 10% | | Kapseln: Temozolomidum 100 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | FI | | | Temozolomid Accord 140 mg | 5 | 292.63 | 352.70 | 10% | | Kapseln: Temozolomidum 140 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | FI | | | Temozolomid Accord 140 mg | 20 | 1031.11 | 1193.55 | 10% | | Kapseln: Temozolomidum 140 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | FI | | | Temozolomid Accord 180 mg | 5 | 318.96 | 382.95 | 10% | | Kapseln: Temozolomidum 180 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | FI | | | Temozolomid Accord 180 mg | 20 | 1275.85 | 1462.20 | 10% | | Kapseln: Temozolomidum 180 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | FI | | | Temozolomid Accord 250 mg | 5 | 445.02 | 527.80 | 10% | | Kapseln: Temozolomidum 250 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
L | | FI | PI | | Posaconazol Accord 100 mg | 24 | 561.21 | 661.30 | 10% | | Magensaftresistente Tabletten: Posaconazolum 100 mg | Accord Healthcare AG | B / SL / SG | FB | | G | |
L | | FI | PI | | Posaconazol Accord 100 mg | 96 | 2244.86 | 2526.00 | 10% | | Magensaftresistente Tabletten: Posaconazolum 100 mg | Accord Healthcare AG | B / SL / SG | FB | | G | |
L | | FI | PI | | AJOVY 225 mg | 1.5 ml | 445.08 | 527.85 | 10% | | Injektionslösung in Fertigspritze: Fremanezumabum 225mg / 1.5ml | Teva Pharma AG | B / SL | FB | | G | |
L | | FI | PI | | AJOVY 225 mg | 3 x 1.5 ml | 1332.62 | 1524.55 | 10% | | Injektionslösung in Fertigspritze: Fremanezumabum 225mg / 1.5ml | Teva Pharma AG | B / SL | FB | | G | |
L | | FI | PI | | Orkambi 100 mg lumacaftor / 125 mg ivacaftor | 56 | 9693.66 | 10191.95 | 10% | | Granulat: 2 Wirkstoffe | Vertex Pharmaceuticals (CH) GmbH | A / SL | FB | | G | |
L | | FI | | | Orkambi 150 mg lumacaftor / 188 mg ivacaftor | 56 | 9693.66 | 10191.95 | 10% | | Granulat: 2 Wirkstoffe | Vertex Pharmaceuticals (CH) GmbH | A / SL | FB | | G | |
L | | FI | | | MVASI 100 mg/4 ml | | 257.57 | 312.40 | 10% | | Infusionskonzentrat: Bevacizumabum 100mg / 4ml | Amgen Switzerland AG | A / SL | FB | | G | |
L | | FI | | | MVASI 400 mg/16 ml | | 962.84 | 1118.60 | 10% | | Infusionskonzentrat: Bevacizumabum 400mg / 16ml | Amgen Switzerland AG | A / SL | FB | | G | |
| | FI | PI | | Delstrigo | 30 | 628.50 | 738.65 | 10% | | Filmtabletten: 3 Wirkstoffe | MSD Merck Sharp & Dohme AG | A / SL | FB | | G | |
| | FI | PI | | Pifeltro | 30 | 436.06 | 517.50 | 10% | | Filmtabletten: Doravirinum 100 mg | MSD Merck Sharp & Dohme AG | A / SL | FB | | G | |
L | | FI | PI | | Talzenna 0.25 mg | 30 | 1557.04 | 1770.90 | 10% | | Kapseln: Talazoparibum | Pfizer AG | A / SL | FB | | G | |
L | | FI | | | Talzenna 1 mg | 30 | 4674.98 | 5042.75 | 10% | | Kapseln: Talazoparibum 1 mg | Pfizer AG | A / SL | FB | | G | |
L | | FI | PI | | Copaxone Pen 40 mg/ml | 12 | 815.29 | 953.30 | 10% | | Injektionslösung im Fertigpen: Glatirameri Acetas 40 mg/ml | Teva Pharma AG | B / SL | FB | | G | |
L | | FI | | | Tremfya 100 mg/1 ml | | 2098.96 | 2365.85 | 10% | | Injektionslösung in einem Fertigpen: Guselkumabum 100 mg/ml | Janssen-Cilag AG | B / SL | FB | | G | |
| | FI | PI | CM | BETADINA, desinfizierende Wundsalbe 10 mg/g | 30 g | PA | PA | k.A. | | Salbe: Iodum 10 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | D | FB | | G | |
| | FI | PI | CM | BETADINA, desinfizierende Wundsalbe 10 mg/g | 100 g | PA | PA | k.A. | | Salbe: Iodum 10 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | D | FB | | G | |
| | FI | | | Rosuvastatin NOBEL 40 mg | 30 | PA | PA | k.A. | | Filmtabletten: Rosuvastatinum 40 mg | NOBEL Pharma Schweiz AG | B | FB | | G | |
| | FI | | | Rosuvastatin NOBEL 40 mg | 105 | PA | PA | k.A. | | Filmtabletten: Rosuvastatinum 40 mg | NOBEL Pharma Schweiz AG | B | FB | | G | |
| | FI | PI | | Copaxone Pen 40 mg/ml | 3 | PA | PA | k.A. | | Injektionslösung im Fertigpen: Glatirameri Acetas 40 mg/ml | Teva Pharma AG | B | FB | | G | |
| | FI | | | Mylotarg 5 mg | | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg | Pfizer AG | A | FB | | G | |
| | | PI | A | Infludo neue Formel | 20 ml | PA | PA | k.A. | | Tropfen zum Einnehmen: 6 Wirkstoffe | Weleda AG | D | FB | | G | |
| | | PI | A | Infludo neue Formel | 50 ml | PA | PA | k.A. | | Tropfen zum Einnehmen: 6 Wirkstoffe | Weleda AG | D | FB | | G | |
| | FI | PI | CM | Betadina | 30 ml | PA | PA | k.A. | | desinfizierende Lösung: Iodum 11 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | D | FB | | G | |
| | FI | PI | CM | Betadina | 120 ml | PA | PA | k.A. | | desinfizierende Lösung: Iodum 11 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | D | FB | | G | |